Loading
Every dated change on the records linked to Leukaemia (all types), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Imatinib with BFM chemotherapy gave four-year disease-free survival of 72.
Hyperfractionated cyclophosphamide did not improve remission, event-free or overall survival; five-year event-free survival was 52.